Fatigue is a common symptom in multiple sclerosis (MS) and often causes difficulties for
both patients and health care providers. As a result of fatigue, individuals with MS …

Fatigue is one of the most common symptoms in multiple sclerosis (MS), with a major impact
on patients' quality of life. Currently, treatment proceeds by trial and error with limited …

Multiple sclerosis (MS) is a chronic, debilitating, inflammatory, and neurodegenerative
disease of the central nervous system (CNS). There is no cure for the disease, and its …

Among patients with multiple sclerosis (MS), fatigue is the most commonly reported
symptom, and one of the most debilitating. Despite its high prevalence and significant …

Fatigue is the most commonly reported symptom of multiple sclerosis (MS), with an
estimated frequency ranging from 76 to 92% 1. Many patients describe fatigue as their most …

Multiple sclerosis (MS) is a neuroinflammatory condition with a prominent progressive
neurodegenerative facet that typically affects young‐or middle‐aged adults. Although …

Multiple sclerosis (MS) is a chronic progressive inflammatory disease of the central nervous
system (CNS) and the major cause of non-traumatic disability in young adults. Fatigue is a …

Objective: To assess whether modafinil, a wakefulness-promoting agent, is useful for fatigue
in patients with multiple sclerosis (MS). Methods: Patients with MS with stable disability, and …

Aim The clinical aim was to provide up-to-date evidence-based recommendations for the
treatment of MS-related fatigue (MSRF). The scientific aim was to prioritise topics for future …

Background: As a symptom of multiple sclerosis (MS), fatigue is difficult to manage because
of its unknown etiology, the lack of efficacy of the drugs tested to date and the absence of …